Carcinoid Tumor  >>  oxaliplatin  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
oxaliplatin / Generic mfg.
NCT00398320: Phase II Capecitabine, Oxaliplatin & Bevacizumab for Metastatic / Unresectable Neuroendocrine Tumors

Completed
2
40
US
Capecitabine, Oxaliplatin, Bevacizumab
Pamela L. Kunz
Neuroendocrine Tumors
10/12
10/12

Download Options